Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Muscular Atrophy × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 837 Neoplasms 582 Prostatic Neoplasms 471 Lung Neoplasms 327 Carcinoma, Non-Small-Cell Lung 302 Colorectal Neoplasms 296 Leukemia, Myeloid, Acute 225 Brain Neoplasms 191 Multiple Myeloma 190 Neoplasm Metastasis 181 Pancreatic Neoplasms 172 Melanoma 155 Carcinoma, Hepatocellular 152 Squamous Cell Carcinoma of Head and Neck 142 Precursor Cell Lymphoblastic Leukemia-Lymphoma 142 Ovarian Neoplasms 142 Head and Neck Neoplasms 140 Glioblastoma 137 Uterine Cervical Neoplasms 127 Sarcoma 119 Lymphoma 116 Recurrence 114 Colonic Neoplasms 111 Glioma 110 Rectal Neoplasms 109 Hematologic Neoplasms 107 Stomach Neoplasms 106 Triple Negative Breast Neoplasms 103 Urinary Bladder Neoplasms 102 Carcinoma, Renal Cell 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04067167 2026-01-20

FREEDOM

University of Erlangen-Nürnberg Medical School

Phase NA Recruiting

Cachexia, Inflammation, Motor Activity, Muscular Atrophy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡